Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19–9 as a Tool for Prognostic Evaluation in Neoadjuvant‐Treated Pancreatic Ductal Adenocarcinoma

Nora Mattila, Riitta Lassila, Harri Mustonen, Caj Haglund, Hanna Seppänen

Open source

DOI
10.1002/cam4.71954
Published
2026-05
Container
Cancer Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.71954,
  title = {Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19–9 as a Tool for Prognostic Evaluation in Neoadjuvant‐Treated Pancreatic Ductal Adenocarcinoma},
  author = {Nora Mattila and Riitta Lassila and Harri Mustonen and Caj Haglund and Hanna Seppänen},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.71954},
  url = {https://doi.org/10.1002/cam4.71954}
}

RIS

TY  - JOUR
TI  - Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19–9 as a Tool for Prognostic Evaluation in Neoadjuvant‐Treated Pancreatic Ductal Adenocarcinoma
AU  - Nora Mattila
AU  - Riitta Lassila
AU  - Harri Mustonen
AU  - Caj Haglund
AU  - Hanna Seppänen
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.71954
UR  - https://doi.org/10.1002/cam4.71954
ER  - 

APA

Mattila, N., Lassila, R., Mustonen, H., Haglund, C., & Seppänen, H. (2026). Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19–9 as a Tool for Prognostic Evaluation in Neoadjuvant‐Treated Pancreatic Ductal Adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.71954

Source records